Goldman Sachs Group Inc Insmed Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Insmed Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,393,049 shares of INSM stock, worth $103 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,393,049
Previous 1,189,901 17.07%
Holding current value
$103 Million
Previous $79.7 Million 27.56%
% of portfolio
0.02%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$62.0 - $79.01 $12.6 Million - $16.1 Million
203,148 Added 17.07%
1,393,049 $102 Million
Q2 2024

Aug 13, 2024
BUY
$22.0 - $69.71 $9.6 Million - $30.4 Million
436,291 Added 57.89%
1,189,901 $79.7 Million
Q1 2024

May 15, 2024
SELL
$25.72 - $29.94 $209,926 - $244,370
-8,162 Reduced 1.07%
753,610 $20.4 Million
Q4 2023

Feb 13, 2024
SELL
$23.42 - $31.74 $2.38 Million - $3.23 Million
-101,746 Reduced 11.78%
761,772 $23.6 Million
Q3 2023

May 14, 2024
BUY
$19.86 - $26.93 $2.02 Million - $2.74 Million
101,746 Added 13.36%
863,518 $21.8 Million
Q3 2023

Nov 14, 2023
BUY
$19.86 - $26.93 $1.39 Million - $1.88 Million
69,834 Added 8.8%
863,518 $21.8 Million
Q2 2023

May 14, 2024
BUY
$16.44 - $21.1 $3.81 Million - $4.89 Million
231,888 Added 41.28%
793,684 $16.7 Million
Q2 2023

Aug 14, 2023
BUY
$16.44 - $21.1 $3.81 Million - $4.89 Million
231,888 Added 41.28%
793,684 $16.7 Million
Q1 2023

May 14, 2024
SELL
$16.26 - $21.73 $7.63 Million - $10.2 Million
-469,100 Reduced 45.5%
561,796 $9.58 Million
Q1 2023

May 11, 2023
SELL
$16.26 - $21.73 $7.63 Million - $10.2 Million
-469,100 Reduced 45.5%
561,796 $9.58 Million
Q4 2022

May 14, 2024
BUY
$16.98 - $23.15 $2.71 Million - $3.7 Million
159,719 Added 18.33%
1,030,896 $20.6 Million
Q4 2022

Feb 13, 2023
BUY
$16.98 - $23.15 $2.71 Million - $3.7 Million
159,719 Added 18.33%
1,030,896 $20.6 Million
Q3 2022

May 14, 2024
BUY
$20.88 - $28.21 $8.41 Million - $11.4 Million
402,677 Added 85.95%
871,177 $18.8 Million
Q3 2022

Nov 10, 2022
BUY
$20.88 - $28.21 $8.41 Million - $11.4 Million
402,677 Added 85.95%
871,177 $18.8 Million
Q2 2022

May 14, 2024
SELL
$17.07 - $25.71 $5.01 Million - $7.54 Million
-293,272 Reduced 38.5%
468,500 $9.24 Million
Q2 2022

Aug 15, 2022
SELL
$17.07 - $25.71 $1.51 Million - $2.27 Million
-88,478 Reduced 15.89%
468,500 $9.24 Million
Q1 2022

May 16, 2022
BUY
$20.42 - $28.13 $1.91 Million - $2.63 Million
93,652 Added 20.21%
556,978 $13.1 Million
Q4 2021

Feb 14, 2022
BUY
$25.89 - $33.45 $5.73 Million - $7.4 Million
221,138 Added 91.31%
463,326 $12.6 Million
Q3 2021

Nov 10, 2021
BUY
$22.46 - $29.47 $5.44 Million - $7.14 Million
242,188 New
242,188 $6.67 Million

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email